Study registry using a special PET scan to stage prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This observational study follows men with prostate cancer who get a specific PET scan (PYLARIFY) to see how well it identifies cancer spread or recurrence. It may help doctors better understand where the cancer is so treatment decisions can be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born male and are at least 21 years old
- You have confirmed prostate cancer based on biopsy/pathology results
- You are either newly diagnosed with suspected spread and have not started prostate cancer treatment, or you have had treatment before and are being checked for recurrence (often with rising PSA)
- You plan to undergo a PET scan using PYLARIFY (not a different PSMA PET tracer)
- You can give consent and are able to follow the study requirements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study checks how well a scan called PyL PET/CT can help find prostate cancer that is high-risk or has come back by blood test. The goal is to improve how doctors detect spread and guide the next treatment steps.
This trial studies how a special PET/CT scan (using 18F-DCFPyL) helps evaluate prostate cancer that is either high-risk at diagnosis or has come back based on PSA blood tests. It may help your care team better stage (map) the cancer and guide next steps.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
This trial tests a new type of PET scan to see how well it finds leftover cancer after you've had focal therapy (treatment to just part of the prostate) for intermediate-risk prostate cancer in the last 9 months.
This study allows people with prostate cancer to get a special PET scan that finds cancer cells. The scan helps doctors plan the best treatment. You may qualify if your PSA is rising or you have high-risk prostate cancer.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.